# Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-abrocitinib-versus-dupilumab-in-adults-with-moderate-to/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Kristian Reich,Jacob P. Thyssen,Andrew Blauvelt,Kilian Eyerich,Weily Soong,Zakiya P. Rice,Hwanhee Hong,Norito Katoh,Fernando Valenzuela,Marco DiBonaventura,Tamara A. Bratt,Fan Zhang,Claire Clibborn,Ricardo Rojo,Hernán Valdez,Urs Kerkmann |
| Citations | 246 |
| DOI | 10.1016/s0140-6736(22)01199-0 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4286515998 |
| PMID | 35871814 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Jacob P. Thyssen](https://scholariq.org/researchers/jacob-p-thyssen/)
- [Marco DiBonaventura](https://scholariq.org/researchers/marco-dibonaventura/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)

## Paper topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Drug-Induced Adverse Reactions](https://scholariq.org/topics/drug-induced-adverse-reactions/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.